A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol describes a dynamic culture system to produce controlled size aggregates of human pluripotent stem cells and further stimulate differentiation in cerebellar organoids under chemically-defined and feeder-free conditions using a single-use bioreactor.
The cerebellum plays a critical role in the maintenance of balance and motor coordination, and a functional defect in different cerebellar neurons can trigger cerebellar dysfunction. Most of the current knowledge about disease-related neuronal phenotypes is based on postmortem tissues, which makes understanding of disease progression and development difficult. Animal models and immortalized cell lines have also been used as models for neurodegenerative disorders. However, they do not fully recapitulate human disease. Human induced pluripotent stem cells (iPSCs) have great potential for disease modeling and provide a valuable source for regenerative approaches. In recent years, the generation of cerebral organoids from patient-derived iPSCs improved the prospects for neurodegenerative disease modeling. However, protocols that produce large numbers of organoids and a high yield of mature neurons in 3D culture systems are lacking. The protocol presented is a new approach for reproducible and scalable generation of human iPSC-derived organoids under chemically-defined conditions using scalable single-use bioreactors, in which organoids acquire cerebellar identity. The generated organoids are characterized by the expression of specific markers at both mRNA and protein level. The analysis of specific groups of proteins allows the detection of different cerebellar cell populations, whose localization is important for the evaluation of organoid structure. Organoid cryosectioning and further immunostaining of organoid slices are used to evaluate the presence of specific cerebellar cell populations and their spatial organization.
The emergence of human pluripotent stem cells (PSCs) represents a excellent tool for regenerative medicine and disease modeling, because these cells can be differentiated into most cell lineages of the human body1,2. Since their discovery, PSC differentiation using diverse approaches has been reported to model different diseases, including neurodegenerative disorders3,4,5,6.
Recently, there have been reports of 3D cultures derived from PSCs resembling huma....
1. Passaging and maintenance of human iPSCs in monolayer culture
The protocol was initiated by promoting cell aggregation using the 0.1 L bioreactors (Figure 1A). Single cell inoculation of the iPSCs was performed, with 250,000 cells/mL seeded in 60 mL of medium with an agitation speed of 27 rpm. This was defined as day 0. After 24 h, the cells efficiently formed spheroid-shaped aggregates (day 1, Figure 1B), and the morphology was well-maintained until day 5, with a gradual increase in size, demonstrating a high degree of ho.......
The need for large cell numbers as well as defined culture conditions to generate specific cell types for drug screening and regenerative medicine applications has been driving the development of scalable culture systems. In recent years, several groups have reported the scalable generation of neural progenitors and functional neurons32,33,34, providing significant advances in the development of new models for neurodegenerative .......
This work was supported by Fundação para a Ciência e a Tecnologia (FCT), Portugal (UIDB/04565/2020 through Programa Operacional Regional de Lisboa 2020, Project N. 007317, PD/BD/105773/2014 to T.P.S and PD/BD/128376/2017 to D.E.S.N.), projects co-funded by FEDER (POR Lisboa 2020—Programa Operacional Regional de Lisboa PORTUGAL 2020) and FCT through grant PAC-PRECISE LISBOA-01-0145-FEDER-016394 and CEREBEX Generation of Cerebellar Organoids for Ataxia Research grant LISBOA-01-0145-FEDER-029298. Funding was also received from the European Union's Horizon 2020 Research and Innovation Programme, under the Grant Agreement number 739572—The Di....
Name | Company | Catalog Number | Comments |
3MM paper | WHA3030861 | Merck | |
Accutase | A6964 - 500mL | Sigma | cell detachment medium |
Anti-BARHL1 Antibody | HPA004809 | Atlas Antibodies | |
Anti-Calbindin D-28k Antibody | CB28 | Millipore | |
Anti-MAP2 Antibody | M4403 | Sigma | |
Anti-N-Cadherin Antibody | 610921 | BD Transduction | |
Anti-NESTIN Antibody | MAB1259-SP | R&D | |
Anti-OLIG2 Antibody | MABN50 | Millipore | |
Anti-PAX6 Antibody | PRB-278P | Covance | |
Anti-SOX2 Antibody | MAB2018 | R&D | |
Anti-TBR1 Antibody | AB2261 | Millipore | |
Anti-TBR2 Antibody | ab183991 | Abcam | |
Anti-TUJ1 Antibody | 801213 | Biolegend | |
Apo-transferrin | T1147 | Sigma | |
BrainPhys Neuronal Medium N2-A & SM1 Kit | 5793 - 500mL | Stem cell tecnhnologies | |
Chemically defined lipid concentrate | 11905031 | ThermoFisher | |
Coverslips 24x60mm | 631-1575 | VWR | |
Crystallization-purified BSA | 5470 | Sigma | |
DAPI | 10236276001 | Sigma | |
Dibutyryl cAMP | SC- 201567B -500mg | Frilabo | |
DMEM-F12 | 32500-035 | ThermoFisher | |
Fetal bovine serum | A3840001 | ThermoFisher | |
Gelatin from bovine skin | G9391 | Sigma | |
Glass Copling Jar | E94 | ThermoFisher | |
Glutamax I | 10566-016 | ThermoFisher | |
Glycine | MB014001 | NZYtech | |
Ham’s F12 | 21765029 | ThermoFisher | |
Human Episomal iPSC Line | A18945 | ThermoFisher | iPSC6.2 |
IMDM | 12440046 | ThermoFisher | |
Insulin | 91077C | Sigma | |
iPS DF6-9-9T.B | WiCell | ||
Iso-pentane | PHR1661-2ML | Sigma | |
L-Ascorbic acid | A-92902 | Sigma | |
Matrigel | 354230 | Corning | basement membrane matrix |
Monothioglycerol | M6154 | Sigma | |
Mowiol | 475904 | Millipore | mounting medium |
mTeSR1 | 85850 -500ml | Stem cell technologies | |
N2 supplement | 17502048 | ThermoFisher | |
Neurobasal | 12348017 | ThermoFisher | |
Paraformaldehyde | 158127 | Sigma | |
PBS-0.1 Single-Use Vessel | SKU: IA-0.1-D-001 | PBS Biotech | |
PBS-MINI MagDrive Base Unit | SKU: IA-UNI-B-501 | PBS Biotech | |
Recombinant human BDNF | 450-02 | Peprotech | |
Recombinant human bFGF/FGF2 | 100-18B | Peprotech | |
Recombinant human FGF19 | 100-32 | Peprotech | |
Recombinant human GDNF | 450-10 | Peprotech | |
Recombinant human SDF1 | 300-28A | Peprotech | |
ROCK inhibitor Y-27632 | 72302 | Stem cell technologies | |
SB431542 | S4317 | Sigma | |
Sucrose | S7903 | Sigma | |
SuperFrost Microscope slides | 12372098 | ThermoFisher | adhesion microscope slides |
Tissue-Tek O.C.T. Compound | 25608-930 | VWR | |
Tris-HCL 1M | T3038-1L | Sigma | |
Triton X-100 | 9002-93-1 | Sigma | |
Tween-20 | P1379 | Sigma | |
UltraPure 0.5M EDTA, pH 8.0 | 15575020 | ThermoFisher |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved